AIDS

Article	Citations
Gut microbiota and plasma metabolites associated with bone mineral density in women with or at risk of HIV infection	93
Keeping up with Streptococcus pneumoniae in children living with HIV: Erratum	83
Real world use of dolutegravir two drug regimens	77
The need to avert emergent resistance to dolutegravir in children and adolescents with HIV	72
A new frontier in HIV care: the predictive power of renal biomarkers on heart health	68
Associations between social determinants of health and comorbidity and multimorbidity in people of black ethnicities with HIV	41
Key milestones and participant engagement strategies in research with HIV-affected adolescents and young adults from low-to-middle income countries	40
Dosing lamivudine or emtricitabine in renal impairment: new data confirm it's time for updated guidance!	40
Long-term persistence of transcriptionally-active “defective” HIV-1 proviruses: Implications for persistent immune activation during antiretroviral therapy	39
Comparison of dolutegravir and efavirenz on depression, anxiety and sleep disorders in pregnant and postpartum women living with HIV	39
Impact of pre-antiretroviral treatment HIV-RNA on time to successful virological suppression and subsequent virological failure – two nationwide, population-based cohort studies	39
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm delivery	39
Explaining racial and ethnic disparities in antiretroviral therapy adherence and viral suppression among U.S. men who have sex with men	37
High-level dolutegravir resistance can emerge rapidly from few variants and spread by recombination: implications for INSTI salvage therapy	36
Virtual case management: a differentiated approach to HIV prevention, treatment, and care	30
Ex-vivo rectal tissue infection with HIV-1 to assess time to protection following oral preexposure prophylaxis with tenofovir disoproxil/emtricitabine	29
Quantifying missed opportunities for tuberculosis among people with HIV in the US President's Emergency Plan for AIDS Relief	29
Social context and tracing household wealth over time in rural Uganda 1994–2018	28
Survival following screening and preemptive antifungal therapy for subclinical cryptococcal disease in advanced HIV infection	28
HIV-1 gp120 amplifies astrocyte elevated gene-1 activity to compromise the integrity of the outer blood–retinal barrier	27
Strategies for managing weight gain associated with antiretroviral therapy: switch or add?	27
Factors influencing antiretroviral therapy switching in people with virologically suppressed HIV-1: a cross-sectional multicenter study in France	26
Life expectancy of people with HIV on antiretroviral therapy in Spain	26
Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV	26
Elevated stress-responsive biomarkers are associated with HIV acquisition in young women in rural South Africa	25

A randomized clinical trial of on-demand oral pre-exposure prophylaxis does not modulate lymphoid/myeloid HIV target cell density in the foreskin	24
Evaluation of HIV-1 reservoir size and broadly neutralizing antibody susceptibility in acute antiretroviral therapy-treated individuals	24
A point-of-care tenofovir urine test improves accuracy of self-reported preexposure prophylaxis adherence and increases condomless sex reporting among young women	23
Differences in HIV clinical outcomes amongst heterosexuals in the United Kingdom by ethnicity	23
Diagnostic accuracy of the re-engineered urinary FujiLAM2 assay amongst hospitalized adults with advanced HIV disease: a prospective cohort study	23
Identifying influential neighbors in social networks and venue affiliations among young MSM: a data science approach to predict HIV infection	23
Incidence and risk factors for recurrent sexually transmitted infections among MSM on HIV pre-exposure prophylaxis	23
Do women with HIV, diabetes mellitus, and full antiretroviral therapy adherence have a lower rate of HIV viremia than men?	23
Hepatitis delta in patients hospitalized in Spain (1997–2018)	23
Characteristics and clinical manifestations of monkeypox among people with and without HIV in the United States: a retrospective cohort	22
Increased risk of false-positive HIV ELISA results after COVID-19	21
Age-associated dementia among older people aging with HIV in the United States: a modeling study	21
Efficacy and safety of tesamorelin in people with HIV on integrase inhibitors	21
Fatty liver disease in children living with HIV: a ghostly iceberg	20
Prevalence of nonalcoholic fatty liver disease using noninvasive techniques among children, adolescents, and youths living with HIV	20
Rapid antiretroviral therapy initiation and its effect on treatment response in MSM in West Africa	20
Enabling timely HIV postexposure prophylaxis access in sub-Saharan Africa	20
Using molecular epidemiology to trace the history of the injection-related HIV epidemic in New York City, 1985–2019	20
Switch back from TAF to TDF or rather switch forward from metabolic toxicities of drugs to metabolic health of people living with HIV	19
Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV	19
Soluble biomarkers associated with chronic lung disease in older children and adolescents with perinatal HIV infection	19
‘Zombie’ proviruses in the spotlight: exploring the dark side of HIV persistence	19
The relationship between alcohol consumption and risk of HIV in married men in Sub-Saharan Africa	19
Identification of hepatitis delta superinfection when investigating transaminitis in HIV/hepatitis B virus co-infection	19
What we have learned from antiretroviral treatment optimization efforts over the last 5 years?	19
Incident depression among Medicare beneficiaries with disabilities and HIV	19
Negative impact of a health insurer-mandated de-simplification from a single-tablet regimen to a two-tablet regimen	19
Applying a machine learning modelling framework to predict delayed linkage to care in patients newly diagnosed with HIV in Mecklenburg County, North Carolina, USA	18
Anal neoplasia: prevention or treatment?	18
Impact of efavirenz on hormone-positive breast cancer survival in women living with HIV	17
Association between low bone mass and fracture prevalence among children living with HIV in Africa	17
Association of T-cell subtypes with macrophage-specific arterial infiltration in people with HIV	17
Cardiovascular outcomes among persons with HIV and nonalcoholic fatty liver disease	17
An agricultural livelihood intervention is associated with reduced HIV stigma among people with HIV	17
Risk factors for pneumococcal carriage in adults living with HIV on antiretroviral therapy in the infant pneumococcal vaccine era in Malawi	17
Serum IgG1 and IgG4 could contribute to partial control of viral rebound in chronically HIV-1-infected patients	16
Ambient air pollution is associated with vascular disease in Ugandan HIV-positive adolescents	16
Inferring population HIV incidence trends from surveillance data of recent HIV infection among HIV testing clients	16
Screening for tuberculosis infection and effectiveness of preventive treatment among people with HIV in low-incidence settings	16
Senescence-related cytokine levels are associated with HIV-1 serostatus and persistence	16
Adipose tissue transcriptome in patients switching efavirenz or a protease inhibitor to raltegravir compared to people without HIV	16
Osteopontin as a potential mediator of inflammation in HIV and comorbid conditions	16
Brain N-acetyl-aspartyl-glutamate is associated with cognitive function in older virally suppressed people with HIV	16
Perinatal outcomes among pregnant women with HIV initiating antiretroviral therapy preconception and antenatally	15
Provision of care for people with HIV migrating from Ukraine: preparing for a long-term response	15
Bictegravir/emtricitabine/tenofovir alafenamide after virologic failure to cabotegravir/rilpivirine	15
The cumulative prevalence of HIV-1 drug resistance in perinatal HIV	15
What happened with preexposure prophylaxis uptake among female sex workers in Zimbabwe? Implications for future prevention programmes	15
Prevalence and incidence of human papilloma virus-related dysplasia of oropharyngeal, cervical, and anal mucosae in Spanish people with HIV	15
Children who are HIV-exposed and uninfected: evidence for action	15

Predictors of intact HIV DNA levels among children in Kenya	15
Rising rates of recent preexposure prophylaxis exposure among men having sex with men newly diagnosed with HIV: antiviral resistance patterns and treatment outcomes	15
Local microbiota dysbiosis contributes to the development of high-risk human papillomavirus-associated anal squamous cell carcinoma	14
Characterization of dolutegravir drug resistance in persons diagnosed with HIV after exposure to long-acting injectable cabotegravir for preexposure prophylaxis	14
Functional variability of Nef in antagonizing SERINC5 during acute to chronic HIV-1 infection	14
The changing prevalence of anemia and risk factors in people with HIV in North America who have initiated ART, 2007–2017	14
Prevalence and resistance patterns of Mycoplasma genitalium infection in people living with HIV: a systematic review and meta-analysis	14
Higher CCR5 density on CD4+ T-cells in mothers and infants is associated with increased risk of in-utero HIV-1 transmission	14
Long-acting cabotegravir/rilpivirine for HIV-1 treatment: real-world evaluation of barriers to implementation	13
Racial/ethnic disparities in estimated undiagnosed HIV infection among adolescents and adults in the United States, 2017–2021	13
Gut-dependent inflammation and alterations of the intestinal microbiota in individuals with perinatal HIV exposure and different HIV serostatus	13
The challenging of HIV care 1 year after of coronavirus disease 2019 pandemic: results from a Brazilian cohort	13
HIV and race are independently associated with endothelial dysfunction	13
Sexually transmitted infections in the preexposure prophylaxis era	13
A note of thanks to our reviewers	13
FDG PET/computed tomography can detect region-specific neuronal changes following antiretroviral therapy in HIV-infected patients	13
Association of CD4 count and HIV viral load with risk of Non-AIDS-defining cancers	13
Addressing atherosclerotic cardiovascular disease risk in persons with HIV	13
‘With age comes wisdom’: effectiveness and tolerability of dolutegravir + lamivudine in virologically-suppressed people with HIV	13
An overview of programmatic indicators to monitor the roll-out of HIV preexposure prophylaxis	13
Coordination of inflammatory responses in children with perinatally acquired HIV infection	13
Potential HIV/ART-mediated germline mutations causing congenital inborn errors of immunity in children born to HIV+ couples: an alarming spectre	13
Plasma microRNAs are associated with domain-specific cognitive function in people with HIV	13
Housing is harm reduction	12
Unit costs of needle and syringe program provision: a global systematic review and cost extrapolation	12
When pandemics collide: measuring the impact of coronavirus disease 2019 on people with HIV	12
Should we continue to use tenofovir disoproxil fumarate/lamivudine/dolutegravir for treatment of pregnant women? Interpreting the PROMISE trial	12
Incidence of non-AIDS defining comorbidities among young adults with perinatally acquired HIV in North America	12
Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV/hepatitis C virus co-infection	12
Association between low skeletal muscle mass and lung function decline in people with HIV: a prospective cohort study	12
Cerebrospinal fluid viral escape can provide clues for the management of HIV-associated neurologic complications: Highlights from the 2023 American Academy of Neurology Annual Meeting, Boston	12
Internalized HIV stigma and viral suppression: examining the mediating and moderating roles of substance use and social support	12
Impact of smoking habits on cardiovascular and neoplastic events and all-cause death in people with HIV from the STOPSHIV cohort	12
Modeling DREAMS impact: trends in new HIV diagnoses among women attending antenatal care clinics in DREAMS countries	12
Adolescent girls and young adult women's HIV infection, male partner age, and HIV status: connecting the dots	12
Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period	12
Is it time to retire efavirenz as a first-line option worldwide?	12
Impact of enhanced adherence counselling on viral re-suppression among adolescents and young persons with persistent viremia	12
Not all clusters are equal: dynamics of molecular HIV-1 clusters in a statewide Rhode Island epidemic	12
TNF-α inhibition in the setting of undiagnosed HIV infection: a call for enhanced screening guidelines	12
The relationship between HIV and reading performance for children in Tanzania	12
Obesity in HIV infection: host-pathogen interaction	12
Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy	12
Initial antiretroviral therapy regimen and risk of heart failure: Erratum	12
Immunogenicity of tetanus, diphtheria and acellular pertussis vaccination among pregnant women living with and without HIV	11
Global health solidarity in the HIV and hypertension disease response	11
A new smoking cessation ‘cascade’ among women with or at risk for HIV infection	11
Risk score prediction for bacteriologically confirmed tuberculosis among adults with HIV on antiretroviral therapy in northwest Ethiopia: prognostic model development	11
COVID-19 in Africa: preexisting immunity and HIV	11
First-trimester exposure to newer antiretroviral agents and congenital anomalies in a US cohort	11
Comparing implications of cardiovascular risk of abacavir and integrase inhibitors: why scientific community is confused and timid?	11
Hazardous alcohol consumption is associated with an increased occurrence of falls among people with HIV in the PROSPER-HIV Study	11
Perinatal HIV infection is associated with deficits in muscle function in children and adolescents in Zimbabwe	11
Circulating micro-RNAs as biomarkers of liver fibrosis progression in hepatitis C virus/HIV-1-co-infected patients: a ‘miR’-velous opportunity of early diagnosis?	11
Development and validation of a multivariable risk prediction model for hepatic steatosis in patients with HIV infection	11
Potential reduction in female sex workers’ risk of contracting HIV during coronavirus disease 2019	10
Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc	10
Dolutegravir regimens have transformed treatment, but ongoing drug resistance research is required to maintain success	10
Racial disparities in cancer risk among MSM with HIV in the United States	10
A 20-year population-based study of all-cause and cause-specific mortality among people with concurrent HIV and psychotic disorders	10
Estimating the influence of Twitter on pre-exposure prophylaxis use and HIV testing as a function of rates of men who have sex with men in the United States	10
Skeletal muscle mitochondrial dysfunction in contemporary antiretroviral therapy: a single cell analysis	10
Identification of a novel HIV-1 second-generation circulating recombinant form (CRF136_0107) among men who have sex with men in China	10
Associations between HIV serostatus and coronary artery plaque volume progression	10
The incidence and dynamic risk factors of chronic kidney disease among people living with HIV – A population-based Cohort Study	10
Estimating the minimum antiretroviral adherence required for plasma HIV-1 RNA viral load suppression among people living with HIV who use unregulated drugs	10
Caregiver fears and assumptions about child HIV status drive not testing children for HIV	10
Global variations in pubertal growth spurts in adolescents living with perinatal HIV	10
Risk and predictors of penile cancer in US Veterans with HIV	10
Auditory and cognitive function in older adults living with and without HIV	10
Posttraumatic stress disorder and its associations with antiretroviral therapy among veterans with HIV	10
HIV-positive Ukrainian refugees in the Czech Republic: a retrospective, observational study	10
Estimated time from HIV infection to diagnosis and diagnosis to first viral suppression during 2014–2018	10
Cytokines in HIV infection: authors’ reply	9
Temporal trends and outcomes of peripheral artery disease revascularization and amputation among the HIV population	9
The entry inhibitor DS003 (BMS-599793): a BMS-806 analogue, provides superior activity as a pre-exposure prophylaxis candidate	9
Cardiovascular risk score associations with frailty in men and women with or at risk for HIV	9
HIV and mpox: a rapid review	9
Factors associated with survival in patients with lymphoma and HIV	9
Are we ready to RESPOND that the question of abacavir's role in cardiovascular disease events is settled?	9

Albumin, white blood cell count, and body mass index improve discrimination of mortality in HIV-positive individuals: Erratum	9
Self-injurious unnatural death among Veterans with HIV	9
Tenofovir alafenamide compared to tenofovir disoproxil fumarate, induces dysglycemia, and dyslipidemia in Wistar rats	9
Fungal diseases are not in the radar of main international HIV conferences	9
Abnormal cognitive aging in people with HIV: evidence from data integration between two countries’ cohort studies	9
HIV-positive donor hearts – a game changer for patients with HIV and organ failure?	9
SARS-CoV-2 antibody prevalence in adults living with HIV	9
The HIV-2 proviral landscape is dominated by defective proviruses	9
Tumor necrosis factor-alpha inhibitors for extended or severe neurological immune reconstitution inflammatory syndrome in HIV-infected patients	9
Addressing the burden of HIV-associated chronic lung disease in West Africa	9
Epstein–Barr virus-associated smooth muscle tumor with multiple lesions in a patient with AIDS	9
Proteinuria and albuminuria among a global primary cardiovascular disease prevention cohort of people with HIV	9
The application of new metrics for understanding trends in undiagnosed HIV among key populations	9
Intracranial vascular imaging detects arterial wall abnormalities in persons with treated HIV infection	9
Needs for shelter or housing assistance among people with diagnosed HIV by jurisdiction: United States, 2015–2020	9
Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa	9
Demographic patterns and disparities in new HIV diagnoses attributed to injection drug use in the United States	9
Home-based HIV testing strategies for middle-aged and older adults in rural South Africa	9
Predictors of adverse pregnancy outcomes among Kenyan women with HIV on antiretroviral treatment in pregnancy	9
Soluble CD14 and IL-12p70 on early ART predict HIV load setpoint after treatment interruption	9
Humoral response 24 months after the first COVID-19 vaccination in people with HIV with and without diabetes	9
A multi-centre observational study of HIV, tuberculosis and risk of chronic lung disease in urban West Africa	8
Baseline HIV drug-resistance testing: 12 US jurisdictions, 2014–2019	8
Bone turnover change after randomized switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV	8
The other side of screening: predictors of treatment and follow-up for anal precancers in a large health system	8
Impact of a livelihood intervention on gender roles and relationship power among people with HIV	8
Understanding the pathways leading to socioeconomic inequalities in HIV testing uptake in 18 sub-Saharan African countries	8
Impact of rosuvastatin on pulse-wave velocity in men with HIV at moderate cardiovascular risk	8
Cost-effectiveness of different intervention strategies of HIV in Zhejiang, China	8
Longitudinal comparison of insulin resistance and dyslipidemia in children with and without perinatal HIV infection in South Africa	8
Distinct antibody profiles in HLA-B ∗ 57 + , HLA-B ∗ 57 − HIV controllers and chronic progressors	8
Clinical decision support systems to guide healthcare providers on HIV testing	8
Years of life lost to cancer among the US HIV population, 2006–2015	8
Enhance harm reduction programmes in responding to the changing trend of drug use and HIV transmission in Asia and the pacific	8
Food insecurity likely contributes to frailty in people with HIV	8
Initial antiretroviral therapy regimen and risk of heart failure	8
Deciphering HIV vaccine-induced Antibody response according to ethnicity	8
The encouraging early successes of a dynamic choice HIV prevention model for both women and men in East Africa	8
Cabotegravir–rilpivirine treatment initiation in a nonvirologically suppressed patient	8
Association between switching to integrase strand transfer inhibitors and incident diabetes in people with HIV	8
Brain aging and cardiovascular factors in HIV: a longitudinal volume and shape MRI study	8
Association of urine biomarkers of kidney health with subclinical cardiovascular disease among men with and without HIV	8
Transplantation of kidneys from donors with HIV: are we there yet?	8
Maternal–foetal transfer of severe acute respiratory syndrome coronavirus 2 antibodies among women with and those without HIV infection	8
Contribution of HIV transmission bursts to future HIV infections, United States	8
Dolutegravir induced neural tube defects in mice are folate responsive	8
Rosuvastatin was not beneficial in reducing arterial stiffness and may be associated with cardiometabolic adverse events in men with HIV	8
TRIM22 genotype is not associated with markers of disease progression in children with HIV-1 infection	8
Association of tenofovir diphosphate and lamivudine triphosphate concentrations with HIV and hepatitis B virus viral suppression	8
Prevalence of detectable HIV-DNA and HIV-RNA in cerebrospinal fluid of youth with perinatal HIV and impaired cognition on antiretroviral therapy	8
Sparse data obscure an unchecked Russian HIV epidemic	8
Source control: treating opioid use disorder among inpatients with related infections, an urgent call to action	8
Monitoring immune recovery on HIV therapy: critical, helpful, or waste of money in the current era?	8
What's up with the decline in beans? Are there simple tests to identify people with HIV at risk for chronic kidney disease?	7
Brain RNA profiling highlights multiple disease pathways in persons with HIV-associated neurocognitive disorder	7
Care interruptions and mortality among adults in Europe and North America	7
Use of tenofovir-based preexposure prophylaxis among pregnant women in South Africa	7
AIDS: changes in leadership	7
Human herpes virus 8-related illness: still with us	7
Cost of improved test and treat strategies in Indonesia	7
Dramatic improvement of MRI abnormalities of HIV encephalopathy after suppressive antiretroviral therapy	7
Differential genome-wide associated variants and enriched pathways of electrocardiogram parameters among people with versus without HIV	7
The effect of an HIV preexposure prophylaxis panel management strategy to increase preexposure prophylaxis prescriptions	7
The barrier functions of crude cervical mucus plugs against HIV-1 infection in the context of cell-free and cell-to-cell transmission	7
Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens	7
Quantifying the association of individual-level characteristics with disparities in kidney transplant waitlist addition among people with HIV	7
Anal cancer incidence in men with HIV who have sex with men: are black men at higher risk?	7
Human galectin-9 promotes the expansion of HIV reservoirs in vivo in humanized mice	7
Incidence of high blood pressure among Kenyan adults with HIV	7
Assessing layered HIV prevention programming: optimizing outcomes for adolescent girls and young women	7
Longitudinal patterns of initiation, persistence, and cycling on preexposure prophylaxis among female sex workers and adolescent girls and young women in South Africa	7
Challenging management of a post-coronavirus disease 2019 invasive Aspergillus sinusitis in a person living with HIV	7
Keeping up with Streptococcus pneumoniae in children living with HIV	7
Risk factors and prognostic significance of anemia in children with HIV infection on antiretroviral therapy	7
Immediate virological failure with intramuscular cabotegravir–rilpivirine in a patient long suppressed with dolutegravir–rilpivirine	7
Mitochondrial dysfunction in people with HIV receiving contemporary antiretroviral therapy	7
Association between tight junction proteins and cognitive performance in untreated persons with HIV	7
Weight loss associated with semaglutide treatment among people with HIV	7
Exposure to doravirine, lamivudine, tenofovir, and raltegravir in a patient with HIV after a Roux-en-Y gastric bypass	7
Peripheral T-cell activation, Th17 cells, regulatory T-cells, and aortic aneurysm in people with HIV	7
Trends in preexposure prophylaxis use among sex partners as reported by persons with HIV – United States, May 2015–June 2020	7
Posttreatment monitoring by ASCL1/LHX8 methylation analysis in women with HIV treated for cervical intraepithelial neoplasia grade 2/3	7
New preexposure prophylaxis options need updated counseling approaches: reframing ‘risk’ in HIV prevention counseling for young sexual and gender minorities of color	7
Acute retroviral syndrome is associated with lower CD4+ T cell nadir and delayed viral suppression, which are blunted by immediate antiretroviral therapy initiation	7
Plasma d-amino acids are associated with markers of immune activation and organ dysfunction in people with HIV	7
Individual and household factors associated with non-disclosure of positive HIV status in a population-based HIV serosurvey	7
Factors associated with insulin resistance in a longitudinal study of Ugandan youth with and without HIV	7
HIV transmission among acutely infected participants of a Dutch cohort study 2015–2021 is not associated with large, clustered outbreaks	7
Deconvoluting the contribution of antiretroviral choice in weight gain	7
Antiretroviral therapy for HIV and intrahepatic hepatitis C virus replication	7
Regional variation in weight change after the transition to dolutegravir in Uganda and South Africa	7
Immunogenicity and reactogenicity of yellow fever vaccine in people with HIV	7
Economic evaluations of differentiated service delivery should include savings and ancillary benefits, not only health system costs: authors’ reply	7
Improving HIV preexposure prophylaxis uptake with artificial intelligence and automation: a systematic review	6
Impacts of religious liberty court case outcomes on pre-exposure prophylaxis accessibility for Medicaid beneficiaries	6